PaulAndrewReyfmanMD

Asthma & COPD, Critical Care Medicine, Interstitial Lung Diseases

Physician

Dr. Reyfman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
Galter Pavilion, 675 N St Clair St Ste 18-250
Chicago, IL 60611
Phone+1 312-695-1800

McGaw Medical Center of Northwestern UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2017
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2011 - 2014
Columbia University Vagelos College of Physicians and SurgeonsClass of 2011

PubMed

1649 citations
SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues.
Carly G. K. Ziegler, Samuel J. Allon, Sarah K. Nyquist, Ian M. Mbano, Vincent N. Miao
Cell. 2020-05-28
228 citations
Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19.
Joana P. Bernardes, Neha Mishra, Florian Tran, Thomas Bahmer, Lena Best
Immunity. 2020-12-15
684 citations
Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary Fibrosis.
Paul A. Reyfman, James M. Walter, Nikita Joshi, Kishore R. Anekalla, Alexandra C. McQuattie-Pimentel
American Journal of Respiratory and Critical Care Medicine. 2019-06-15

Northwestern Doctor Awarded ATS Foundation/Boehringer Ingelheim Fellowship for IPF ResearchApril 15th, 2019
ATS Foundation/Boehringer Ingelheim Pharmaceuticals Inc. Research Fellowship in Idiopathic Pulmonary FibrosisApril 8th, 2019